Approval · Notice of Compliance 11002 · 2010
APX-RANITIDINE: Notice of Compliance 11002
Issued February 5, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11002
- Date
- February 5, 2010
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Histamine H2 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APX-RANITIDINE | 02342871 | — |
| APX-RANITIDINE | 02342898 | — |
Medicinal ingredients
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB